Get started
Author

Sarah Ronnebaum

ORCID: 0000-0003-4787-754X
Observed ORCID: 0000-0003-4787-754X
OpenAlex ID: A5120851183
Burden of thromboembolism, disease progression, and phlebotomy among polycythemia vera patients in the United States: a systematic literature review
2026 · Naveen Pemmaraju, Qi Fan, et al. · Expert Review of Hematology · 1
Survival benefit of oral systemic monotherapy in previously treated metastatic colorectal cancer: a meta-analysis
2026 · Per Pfeiffer, Chiara Cremolini, et al. · The Oncologist · 1
Graves’ disease: review of disease characteristics, burden, and treatments
2026 · Lesley-Ann Miller-Wilson, Erin Mandal, et al. · Frontiers in Endocrinology
PDF
Burden of thromboembolism, disease progression, and phlebotomy among polycythemia vera patients in the United States: a systematic literature review
2026 · Naveen Pemmaraju, Qi Fan, et al. · Figshare
Hpr81 Breakthrough Therapy (bt) and Fast Track (ft) Designations in New Drug Applications and Biologic License Applications (ndas/blas) to Fda’s Center for Drug Evaluation and Research (cder), 2013-2025
2026 · Sarah Ronnebaum · Value in Health
Hpr15 Trends and Postmarketing Outcomes of Accelerated Approvals (aas) in Fda New Drug Applications and Biologic License Applications (ndas/blas) From 1992-2025
2026 · Sarah Ronnebaum · Value in Health
SA38 Enhancing Targeted Literature Reviews (TLRs) with Artificial Intelligence (AI): A Methodological Approach for Conducting Efficient Targeted Searches
2025 · Caroline von Wilamowitz-Moellendorff, Rajat Goel, et al. · Value in Health
Works count: 7
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type